j.dib.2015.12.024

Recombinant Human IGF-I Protein Summary

    Description
    Recombinant bioactive protein for Human IGF-I

    Source:E. coli
    Amino Acid Sequence:(P01343)

    Preparation
    Method
    >97% SDS-PAGE
    Details of Functionality
    The ED50 as determined by a cell proliferation assay using NIH3T3 cells is typically 1-6 ng/ml.
    Source
    E. coli
    Protein/Peptide Type
    Biologically Active Protein
    Gene
    IGF1
    Purity
    >95%, by SDS-PAGE
    Endotoxin Note
    <0.1 ng/ug

Applications/Dilutions

    Theoretical MW
    9.11 kDa.
    Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.

Packaging, Storage & Formulations

    Storage
    Store at -20 to -80C. Avoid freeze-thaw cycles.
    Buffer
    Lyophilized with no additives
    Concentration
    Lyoph
    Purity
    >95%, by SDS-PAGE
    Reconstitution Instructions
    Reconstitute in dH2O or 10 mM AcOH to 1.0 mg/ml. This solution can then be diluted into other buffered solutions or stored at 4C for 1 week or -20C for future use.

Alternate Names for Recombinant Human IGF-I Protein

      IBP1
      IGF1
      IGF-1
      IGF1A
      IGFI
      IGF-I
      IGF-IA
      IGF-IB
      insulin-like growth factor 1 (somatomedin C)
      insulin-like growth factor 1
      insulin-like growth factor I
      insulin-like growth factor IA
      insulin-like growth factor IB
      Mechano growth factor
      MGF
      Somatomedin A
      Somatomedin C
      somatomedin-C

Background

IGF-I (insulin-like Growth Factor-I) is a polypeptide growth factor that stimulates the proliferation of a wide range of cell types including muscle, bone, and cartilage tissue. s recombinant human IGF-I is a N-terminus modified IGF-I with a Long R3 chain, which shows higher potency than regular human IGF-I in bioactivity assay. The recombinant IGF-I Long R3 was produced from E. coli using Animal Origin Free (AOF) components and therefore it is suitable for bioproduction also. The product can be provided as lyophilized form or liquid form, stable for at least two years.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Peptides and proteins are guaranteed for 2 years from date of receipt.

Bardoxolone (methyl)

Related Post